Health
Novel T-cell therapy shows promise to treat COVID-19 in high-risk patients – Healio
An off-the-shelf, virus-specific T-cell therapy demonstrated proof of concept to enter a clinical trial for the treatment of severe COVID-19 infection, according…
Source/Disclosures
Source: Vasileiou S, et al. Abstract 612. Presented at: ASH Annual Meeting and Exposition (virtual meeting); Dec. 5-8, 2020.
Disclosures:
Vasileiou reports a consultant role with and research funding from AlloVir. Please see the abstract for all other researchers’ relevant financial disclosures.
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected] to Healio
An off-the-shelf, virus-specific…
-
Noosa News18 hours agoCommissioner thanks police officer who threw a speed radar at a car
-
Noosa News16 hours agoNo matter what happens in his Origin debut, history beckons for rookie maroon Robert Toia
-
Noosa News22 hours agoBrisbane Broncos star Reece Walsh says punching friend in face ‘not a good look’
-
General14 hours agoDairy farmers devastated by floods across parts of New South Wales